Biotech ETFs to Watch As Patent Reform Bill Heats Up
While the biotechnology sector and exchange traded funds (ETFs) are rocking the performance charts, an old issue is once again on the table in Washington: patent reform. If it finally comes through, it could mean big things. The...
Read More

